Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and ...

U.S. biotechnology stocks dropped sharply on Monday following the resignation of Peter Marks, the top vaccine official at the Food and Drug Administration, raising uncertainty over regulatory ...

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.